Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca

Journal of Analytical Toxicology

Volumn 20, Issue 6, 1996, Pages 492-497

  Callaway, James C ^a   Raymon, Lionel P ^b   Hearn, William L ^c   McKenna, Dennis J ^d   Grob, Charles S ^e   Brito, Glacus S ^f   Mash, Deborah C ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c Miami Dade Medical Examiner Department   (United States)

^d Botanical Dimensions   (United States)

^e HARBOR UCLA MEDICAL CENTER   (United States)

^f Ctro Estud Medico Da Uniao do Veg   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AYAHUASCA; HARMALINE; HARMINE; N,N DIMETHYLTRYPTAMINE; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ARTICLE; BEVERAGE; BRAZIL; CONCENTRATION RESPONSE; CULTURAL ANTHROPOLOGY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; QUANTITATIVE DIAGNOSIS;

EID: 0029839207     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/20.6.492     Document Type: Article

References (16)

1. R.E. Schultes and A. Holmann. In Plants of the Gods: Their Sacred, Healing and Hallucinogenic Powers. Healing Arts Press, Rochester, VT, 1992, pp 120-27.
2. R. Spruce. On some remarkable narcotics [sic] of the Amazon valley and Orinoco ocean highways. Geographi. Revi. 1(55): 184-93 (1873).
3. J. Ott. Ayahuasca Analogues: Pangaean Entheogens. Natural Products Co., Kennewick, WA, 1994.
4. J.F. Casale and J.E. Koles. Analysis of ayahuasca ('Santo Daime' [sic]). Microgram 28(9): 296-99 (1995).
5. F.A. Hochstein and A.M. Paradies. Alkaloids of Banisteria caapi and Prestonia amazonicum [sic]. J. Am. Chem. Soc. 79: 5735-36 (1957).
6. R.J. Strassman, C.R. Quails, and L. Berg. Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biol. Psych. 39: 784-95 (1996).
7. G.E. Liwszyc, E. Vuori, I. Rasanen, and J. Issakainen. Daime - a ritual herbal potion. J. Ethnopharmacol. 36(1): 91-92 (1992).
8. D.J. McKenna, G.H.N. Towers, and F. Abbot. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. J. Ethnopharmacol. 10(2): 195-23 (1984).
9. J.C. Callaway. DMTs in the human brain. In Yearbook for Ethnomedicine and the Study of Consciousness, vol. 4. Verlag Fur Wissenschaft Und Bildung, Berlin, Germany, 1996, pp 45-54.
10. N.S. Buckholtz and W.O. Boggan. Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure activity relationships and substrate specificity. Biochem. Pharmacol. 26: 1991-96 (1977).
11. P.J. Neuvonen, S. Pohjola-Sintonen, U. Tacke, and E. Vuori. Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses. Lancet 342: 1419 (1993).
12. H. Sternbach. The serotonin syndrome. Am. J. Psychiatry. 148: 705-13 (1991).
13. M. Demirkiran, J. Jankovic, and J.M. Dean. Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome. Clin. Neuropharmacol. 19(2): 157-64 (1996).
14. R.J. Strassman and C.R. Quails. Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic and cardiovascular effects. Arch. Gen. Psychiatry 51: 85-97 (1994).
15. R.J. Strassman, C.R. Quails, E.H. Uhlenhuth, and R. Kellner. Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch. Gen. Psychiatry 51: 98-108 (1994).
16. J.D. Coplan and J.M. Gorman. Detectable levels of fluoxetine metabolites after discontinuation: an unexpected serotonin syndrome. Am. J. Psychiatry. 150: 837 (1993).